153 related articles for article (PubMed ID: 32623838)
1. Immunotherapy in sinonasal melanoma: treatment patterns and outcomes compared to cutaneous melanoma.
Klebaner D; Saddawi-Konefka R; Finegersh A; Yan CH; Califano JA; London NR; Deconde AS; Faraji F
Int Forum Allergy Rhinol; 2020 Sep; 10(9):1087-1095. PubMed ID: 32623838
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Primary Versus Salvage Surgery for Sinonasal Malignancies: A Population-Based Analysis.
Lehrich BM; Yasaka TM; Goshtasbi K; Kuan EC
Laryngoscope; 2021 Mar; 131(3):E710-E718. PubMed ID: 32706415
[TBL] [Abstract][Full Text] [Related]
3. Treatment modalities in sinonasal mucosal melanoma: A national cancer database analysis.
Ganti A; Raman A; Shay A; Kuhar HN; Auger SR; Patel T; Kuan EC; Diaz AZ; Batra PS; Tajudeen BA
Laryngoscope; 2020 Feb; 130(2):275-282. PubMed ID: 31021415
[TBL] [Abstract][Full Text] [Related]
4. Disparities of Immunotherapy Utilization in Patients with Stage III Cutaneous Melanoma: A National Perspective.
Al-Qurayshi Z; Crowther JE; Hamner JB; Ducoin C; Killackey MT; Kandil E
Anticancer Res; 2018 May; 38(5):2897-2901. PubMed ID: 29715114
[TBL] [Abstract][Full Text] [Related]
5. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma.
McLean N; Tighiouart M; Muller S
Oral Oncol; 2008 Nov; 44(11):1039-46. PubMed ID: 18396446
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
Robin TP; Jones BL; Gordon OM; Phan A; Abbott D; McDermott JD; Goddard JA; Raben D; Lanning RM; Karam SD
Cancer; 2017 Aug; 123(16):3040-3049. PubMed ID: 28369832
[TBL] [Abstract][Full Text] [Related]
7. Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.
Samstein RM; Carvajal RD; Postow MA; Callahan MK; Shoushtari AN; Patel SG; Lee NY; Barker CA
Head Neck; 2016 Sep; 38(9):1310-7. PubMed ID: 27043023
[TBL] [Abstract][Full Text] [Related]
8. Open Versus Endoscopic Approach for Sinonasal Melanoma: A Systematic Review and Meta-analysis.
Hur K; Zhang P; Yu A; Kim-Orden N; Kysh L; Wrobel B
Am J Rhinol Allergy; 2019 Mar; 33(2):162-169. PubMed ID: 30616359
[TBL] [Abstract][Full Text] [Related]
9. Improved Survival with Immunotherapy but Lack of Synergistic Effect with Radiation for Stage IV Melanoma of the Head and Neck.
Babcock B; Rodrigues M; Kearns D; Solomon N; Reeves ME; Senthil M; Garberoglio CA; Namm JP
Am Surg; 2019 Oct; 85(10):1118-1124. PubMed ID: 31657306
[TBL] [Abstract][Full Text] [Related]
10. Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit?
Teitelbaum JI; Issa K; Barak IR; Ackall FY; Jung SH; Jang DW; Abi Hachem R
Otolaryngol Head Neck Surg; 2020 Nov; 163(5):986-991. PubMed ID: 32600116
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic and open surgical approaches to locally advanced sinonasal melanoma: comparing the therapeutic benefits.
Swegal W; Koyfman S; Scharpf J; Sindwani R; Greskovich J; Borden E; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):840-5. PubMed ID: 25077703
[TBL] [Abstract][Full Text] [Related]
12. Treatment and prognosis in sinonasal mucosal melanoma: A retrospective analysis of 65 patients from a single cancer center.
Sun CZ; Li QL; Hu ZD; Jiang YE; Song M; Yang AK
Head Neck; 2014 May; 36(5):675-81. PubMed ID: 23606507
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.
Amit M; Tam S; Abdelmeguid AS; Kupferman ME; Su SY; Raza SM; DeMonte F; Hanna EY
Ann Surg Oncol; 2018 Jun; 25(6):1723-1729. PubMed ID: 29626308
[TBL] [Abstract][Full Text] [Related]
14. Current concepts in advanced sinonasal mucosal melanoma: a single institution experience.
Meerwein CM; Hüllner M; Braun R; Soyka MB; Morand GB; Holzmann D
Eur Arch Otorhinolaryngol; 2019 Aug; 276(8):2259-2265. PubMed ID: 31098872
[TBL] [Abstract][Full Text] [Related]
15. Sinonasal mucosal melanoma: A 44-case study and literature analysis.
Dréno M; Georges M; Espitalier F; Ferron C; Charnolé A; Dréno B; Malard O
Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Sep; 134(4):237-242. PubMed ID: 28442409
[TBL] [Abstract][Full Text] [Related]
16. Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma.
Bateni SB; Nguyen P; Eskander A; Seung SJ; Mittmann N; Jalink M; Gupta A; Chan KKW; Look Hong NJ; Hanna TP
JAMA Dermatol; 2023 Nov; 159(11):1195-1204. PubMed ID: 37672282
[TBL] [Abstract][Full Text] [Related]
17. A National Cancer Database Analysis of Sinonasal Malignant Myoepithelial Carcinoma Outcomes.
Eide JG; Kshirsagar RS; Brant JA; Palmer JN; Adappa ND
Am J Rhinol Allergy; 2023 Jan; 37(1):7-12. PubMed ID: 35971225
[TBL] [Abstract][Full Text] [Related]
18. Prolonged overall survival following metastasectomy in stage IV melanoma.
Elias ML; Behbahani S; Maddukuri S; John AM; Schwartz RA; Lambert WC
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1719-1725. PubMed ID: 31070816
[TBL] [Abstract][Full Text] [Related]
19. Demographics and treatment trends in sinonasal mucosal melanoma.
Gal TJ; Silver N; Huang B
Laryngoscope; 2011 Sep; 121(9):2026-33. PubMed ID: 22024859
[TBL] [Abstract][Full Text] [Related]
20. Patterns of care and outcomes of proton and eye plaque brachytherapy for uveal melanoma: Review of the National Cancer Database.
Lin AJ; Rao YJ; Acharya S; Schwarz J; Rao PK; Grigsby P
Brachytherapy; 2017; 16(6):1225-1231. PubMed ID: 28966081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
